Aliases & Classifications for Pulmonary Edema

Aliases & Descriptions for Pulmonary Edema:

Name: Pulmonary Edema 12 42 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:11396
ICD10 33 J81 J81.1
MeSH 42 D011654
NCIt 47 C26868
UMLS 69 C0034063

Summaries for Pulmonary Edema

MalaCards based summary : Pulmonary Edema is related to renovascular hypertension and gastric dilatation, and has symptoms including edema, hemoptysis and joint swelling. An important gene associated with Pulmonary Edema is ACE (Angiotensin I Converting Enzyme), and among its related pathways/superpathways are Toll-Like receptor Signaling Pathways and Toll-like Receptor Signaling Pathway. The drugs Benzocaine and Zinc have been mentioned in the context of this disorder. Affiliated tissues include lung, heart and endothelial, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and cardiovascular system

Wikipedia : 71 Pulmonary edema is fluid accumulation in the tissue and air spaces of the lungs. It leads to impaired... more...

Related Diseases for Pulmonary Edema

Diseases related to Pulmonary Edema via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 419)
id Related Disease Score Top Affiliating Genes
1 renovascular hypertension 29.6 CXCL8 EDN1 NOS3
2 gastric dilatation 29.6 CXCL8 IL10 TNF
3 influenza 29.5 F2 REN SERPINC1
4 heart disease 29.4 ACE CRP TRPV4
5 neuropathy 29.3 CRP CXCL8 IL1B TNF
6 lupus erythematosus 29.2 ACE CRP SERPINC1
7 cataract 29.1 CRP IL1B SERPINC1 TNF
8 myocardial infarction 27.8 ACE CRP EDN1 F2 ICAM1 IL10
9 pulmonary edema of mountaineers 11.9
10 adult respiratory distress syndrome 11.7
11 acute respiratory distress syndrome 11.4
12 acute mountain sickness 11.4
13 hantavirus pulmonary syndrome 11.1
14 toxic pneumonitis 11.1
15 chronic mountain sickness 10.8
16 congenital cataracts, facial dysmorphism, and neuropathy 10.8
17 intussusception 10.4 IL1B TNF
18 proliferating trichilemmal cyst 10.3 EDN1 NOS3
19 hypotrichosis simplex 10.3 ACE REN
20 pyridoxal 5'-phosphate-dependent epilepsy 10.3 IL10 TNF
21 aplasia cutis congenita recessive 10.3 ACE EDN1 NOS3
22 uterine inflammatory disease 10.3 EDN1 REN
23 eye degenerative disease 10.3 ACE NOS3 NPPB
24 chronic inflammatory demyelinating polyneuropathy 10.3 NPPB REN
25 ectodermal dysplasia 9, hair/nail type 10.3 EDN1 NOS3 NPPB
26 aphasia 10.3 ACE EDN1 NOS3
27 tubular renal disease-cardiomyopathy syndrome 10.3 IL10 TNF
28 esophagus lymphoma 10.3 CXCL8 EDN1 TNF
29 gastroduodenal crohn's disease 10.3 IL1B NOS3 TNF
30 hyperinsulinemic hypoglycemia, familial, 3 10.3 ACE REN
31 conidiobolomycosis 10.3 CXCL8 IL10 TNF
32 plantar wart 10.3 CXCL8 IL10 TNF
33 childhood electroclinical syndrome 10.3 CXCL8 IL10 IL1B
34 trichomalacia 10.3 CXCL8 IL10 TNF
35 ovarian cystic teratoma 10.3 CXCL8 IL1B TNF
36 nasal cavity cancer 10.2 CXCL8 IL1B TNF
37 hypoparathyroidism-retardation-dysmorphism syndrome 10.2 IL10 IL1B TNF
38 peripheral artery disease 10.2 ACE IL10 TNF
39 rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies 10.2 IL10 IL1B TNF
40 oppositional defiant disorder 10.2 ACE EDN1 NOS3 TNF
41 gonococcal endophthalmia 10.2 IL10 IL1B TNF
42 colonic lymphangioma 10.2 ACE PIK3C2A
43 right ventricle hypoplasia 10.2 ICAM1 REN TNF
44 rickettsialpox 10.2 IL10 IL1B TNF
45 bladder signet ring cell adenocarcinoma 10.2 IL10 IL1B TNF
46 nasopharyngitis 10.2 CXCL8 IL1B TNF
47 stenosis of lacrimal sac 10.2 CXCL8 IL1B TNF
48 baritosis 10.2 CXCL8 IL1B TNF
49 neurotic disorder 10.2 ICAM1 IL10 TNF
50 petrositis 10.2 ACE EDN1 NPPB REN

Graphical network of the top 20 diseases related to Pulmonary Edema:



Diseases related to Pulmonary Edema

Symptoms & Phenotypes for Pulmonary Edema

UMLS symptoms related to Pulmonary Edema:


edema, hemoptysis, joint swelling

GenomeRNAi Phenotypes related to Pulmonary Edema according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.92 ICAM1 ACE IL10 CFTR IL1B CXCL8
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.92 ICAM1 ACE IL10 CFTR IL1B CXCL8

MGI Mouse Phenotypes related to Pulmonary Edema:

44 (show all 15)
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.41 ACE CRP EDN1 F2 ICAM1 IL10
2 homeostasis/metabolism MP:0005376 10.38 SERPINC1 TNF TRPV4 ACE CFTR CRP
3 hematopoietic system MP:0005397 10.31 ACE CFTR F2 ICAM1 IL10 IL1B
4 immune system MP:0005387 10.27 TNF ACE CFTR CRP F2 ICAM1
5 behavior/neurological MP:0005386 10.25 ACE CFTR F2 IL10 NOS2 NOS3
6 growth/size/body region MP:0005378 10.25 REN TNF ACE CFTR EDN1 F2
7 mortality/aging MP:0010768 10.22 ACE CFTR EDN1 F2 ICAM1 IL10
8 digestive/alimentary MP:0005381 10.13 CFTR EDN1 F2 ICAM1 IL10 NOS2
9 nervous system MP:0003631 10.1 SERPINC1 TNF TRPV4 EDN1 F2 ICAM1
10 muscle MP:0005369 10.02 EDN1 ICAM1 IL10 NOS2 NOS3 NPPA
11 liver/biliary system MP:0005370 9.98 ACE CFTR IL10 NOS2 NOS3 SERPINC1
12 renal/urinary system MP:0005367 9.91 ACE EDN1 NOS2 NOS3 NPPA PIK3C2A
13 reproductive system MP:0005389 9.81 ACE CFTR F2 IL10 NOS2 NOS3
14 respiratory system MP:0005388 9.5 CFTR F2 IL10 NOS2 NOS3 TNF
15 vision/eye MP:0005391 9.23 CFTR ICAM1 IL10 NOS2 NOS3 SERPINC1

Drugs & Therapeutics for Pulmonary Edema

Drugs for Pulmonary Edema (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 324)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved Phase 4,Phase 1,Phase 2 1994-09-7, 94-09-7 2337
2
Zinc Approved Phase 4 7440-66-6 32051 23994
3
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
4
Spironolactone Approved Phase 4 1952-01-7, 52-01-7 5833
5
Furosemide Approved, Vet_approved Phase 4,Phase 3,Phase 2 54-31-9 3440
6
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456
7
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
8
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
9
Remifentanil Approved Phase 4,Phase 2 132875-61-7 60815
10
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
11
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
12
Morphine Approved, Investigational Phase 4 57-27-2 5288826
13
Budesonide Approved Phase 4 51333-22-3 63006 5281004
14
Epoprostenol Approved Phase 4 61849-14-7, 35121-78-9 5280427 5282411
15
Treprostinil Approved, Investigational Phase 4 81846-19-7 54786 6918140
16
Tolvaptan Approved Phase 4,Phase 3 150683-30-0 216237
17
Histamine Approved, Investigational Phase 4 75614-87-8, 51-45-6 774
18
Magnesium Sulfate Approved, Vet_approved Phase 4,Phase 3 7487-88-9 24083
19
Glycerol Approved, Experimental Phase 4 56-81-5 753
20
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
21
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
22
Chlorothiazide Approved, Vet_approved Phase 4 58-94-6 2720
23
Metolazone Approved Phase 4 17560-51-9 4170
24 tannic acid Approved, Nutraceutical Phase 4,Phase 1,Phase 2
25 Hypoglycemic Agents Phase 4,Phase 3,Phase 2
26 insulin Phase 4,Phase 3,Phase 2
27 Insulin, Globin Zinc Phase 4,Phase 3,Phase 2
28 Anesthetics Phase 4,Phase 3,Phase 2
29 Anesthetics, General Phase 4,Phase 2
30 Anesthetics, Inhalation Phase 4
31 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
32 Platelet Aggregation Inhibitors Phase 4,Phase 2
33 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
34 diuretics Phase 4,Phase 3,Phase 2
35 Diuretics, Potassium Sparing Phase 4
36 Hormone Antagonists Phase 4,Phase 1,Phase 2
37 Hormones Phase 4,Phase 3,Phase 1,Phase 2
38 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 1,Phase 2
39 Mineralocorticoid Receptor Antagonists Phase 4
40 Mineralocorticoids Phase 4
41 Natriuretic Agents Phase 4,Phase 3,Phase 2
42 Sodium Channel Blockers Phase 4
43 Vasodilator Agents Phase 4,Phase 1,Phase 2,Early Phase 1
44 Antihypertensive Agents Phase 4,Phase 1
45 Arginine Vasopressin Phase 4,Phase 3,Phase 2
46 Vasopressins Phase 4,Phase 3,Phase 2
47 Anticoagulants Phase 4
48 Calcium, Dietary Phase 4,Phase 3,Phase 1,Phase 2
49 Chelating Agents Phase 4,Phase 3
50 Phosphodiesterase 5 Inhibitors Phase 4,Phase 1,Phase 2,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 291)
id Name Status NCT ID Phase
1 Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn Unknown status NCT01499238 Phase 4
2 Normoglycemia and Neurological Outcome Unknown status NCT01137773 Phase 4
3 A Comparison of Two Anaesthetic Methods of Protecting Heart Tissue During Cardiac Surgery Unknown status NCT00244283 Phase 4
4 Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure. Unknown status NCT00331656 Phase 4
5 Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Unknown status NCT00584350 Phase 4
6 Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension Unknown status NCT01468571 Phase 4
7 Fluid Shifts During Resuscitation: Impacts on Macrocirculation and Microcirculation Unknown status NCT00326729 Phase 4
8 Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema Completed NCT00912158 Phase 4
9 CPAP Versus NPPV in ACPE Completed NCT00446498 Phase 4
10 Non-Invasive Ventilation in Pulmonary Edema Completed NCT00453947 Phase 4
11 OUT-OF-HOSPITAL CPAP STUDY Completed NCT00439075 Phase 4
12 Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness Completed NCT00627965 Phase 4
13 Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach Completed NCT02135146 Phase 4
14 Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude Completed NCT02024386 Phase 4
15 Acute Chest Pain Treatment and Evaluation (ACTION) Study Completed NCT00434564 Phase 4
16 Diffuse Acute Respiratory Distress Syndrome (ARDS), Recruitment Maneuver, and sRAGE (DAMAGE Study) Completed NCT01600651 Phase 4
17 Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening Completed NCT00162565 Phase 4
18 Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade Completed NCT02403063 Phase 4
19 Effect-site Concentration of Remifentanil for Smooth Removal of the Double-lumen Endotracheal Tube Completed NCT02528825 Phase 4
20 Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing Completed NCT01993667 Phase 4
21 Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture Completed NCT01961895 Phase 4
22 Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00202189 Phase 4
23 Hypertonic Saline-hetastarch in Cardiac Surgery Completed NCT00469716 Phase 4
24 Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin Completed NCT00373360 Phase 4
25 Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients Completed NCT01439009 Phase 4
26 Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS) Recruiting NCT01763853 Phase 4
27 Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients Recruiting NCT01503671 Phase 4
28 The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children Recruiting NCT02743663 Phase 4
29 REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study Active, not recruiting NCT01424150 Phase 4
30 NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema Active, not recruiting NCT00143793 Phase 4
31 MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial) Not yet recruiting NCT02856698 Phase 4
32 Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP) Not yet recruiting NCT03068741 Phase 4
33 Different Schemes of Magnesium Sulfate for Preeclampsia Terminated NCT02396030 Phase 4
34 Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan Terminated NCT00840463 Phase 4
35 Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH Terminated NCT00439946 Phase 4
36 Rapid Switch From Flolan to Remodulin in the Outpatient Clinic Terminated NCT00643604 Phase 4
37 Protocolized Diuretic Strategy in Cardiorenal Failure Terminated NCT01921829 Phase 4
38 Use of Nesiritide in the Management of Acute Diastolic Heart Failure Terminated NCT00083772 Phase 4
39 Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF Withdrawn NCT00505791 Phase 4
40 High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure Withdrawn NCT02429388 Phase 4
41 Bilevel Positive Pressure Ventilation (BIPAP)in Patients With Sleep Disorders Breathing (SDB)and Congestive Heart Failure (CHF):Comparison of Two Diagnostic Methods Unknown status NCT01501734 Phase 3
42 Concomitant Tracheostomy and Lung Resection Unknown status NCT01053624 Phase 3
43 Study of Ablation for the Pulmonary Focal Pure Ground Glass Opacity (pGGO) Unknown status NCT01429649 Phase 3
44 CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema Completed NCT00213681 Phase 3
45 Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema Completed NCT00390442 Phase 3
46 Continuous Positive Airway Pressure for Acute Pulmonary Edema Completed NCT00554580 Phase 3
47 Non-Invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema: a Multicentre Study Completed NCT00785174 Phase 3
48 Is Plasma Transfusion Beneficial Prior to Low-Risk Procedures in Hospitalized Patients With Blood Clotting Abnormalities? Completed NCT00953901 Phase 3
49 Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness Completed NCT00664001 Phase 3
50 A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months Completed NCT01508247 Phase 3

Search NIH Clinical Center for Pulmonary Edema

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: pulmonary edema

Genetic Tests for Pulmonary Edema

Anatomical Context for Pulmonary Edema

MalaCards organs/tissues related to Pulmonary Edema:

39
Lung, Heart, Endothelial, Brain, Kidney, Spinal Cord, Neutrophil

Publications for Pulmonary Edema

Articles related to Pulmonary Edema:

(show top 50) (show all 783)
id Title Authors Year
1
Recurrence of non-cardiogenic pulmonary edema and sustained hypotension shock in cystic pheochromocytoma. ( 28471119 )
2017
2
Susceptibility To High Altitude Pulmonary Edema Is Associated With A More Uniform Distribution Of Regional Specific Ventilation. ( 28057815 )
2017
3
Acute pulmonary edema caused by takotsubo cardiomyopathy in a pregnant woman undergoing transvaginal cervical cerclage: A case report. ( 28072695 )
2017
4
16-Year-Old Female Near Hanging With Negative Pressure Pulmonary Edema. ( 28089063 )
2017
5
Hypoxia-Induced Inflammatory Chemokines in Subjects with a History of High-Altitude Pulmonary Edema. ( 26855492 )
2016
6
Unilateral Pulmonary Edema Due to Leaflet Fracture of a Duromedics Edwards Bileaflet Mitral Valve. ( 27692700 )
2016
7
Non-cardiogenic pulmonary edema, rhabdomyolysis and myocardial injury following heroin inhalation: a case report. ( 27895451 )
2016
8
Prevalence of pulmonary edema among the deceased cases with acute Methadone poisoning: A report from Iran. ( 27843967 )
2016
9
Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema. ( 26963356 )
2016
10
Levels of interleukin-6, superoxide dismutase and malondialdehyde in the lung tissue of a rat model of hypoxia-induced acute pulmonary edema. ( 26998026 )
2016
11
Reexpansion pulmonary edema after surgery for spontaneous pneumothorax in a patient with anorexia nervosa. ( 27158490 )
2016
12
High Altitude Pulmonary Edema Without Appropriate Action Progresses to Right Ventricular Strain: A Case Study. ( 27575244 )
2016
13
Influenza leaves a TRAIL to pulmonary edema. ( 26999598 )
2016
14
PATIENT-VENTILATION ASYNCHRONY CAUSING NEGATIVE PRESSURE PULMONARY EDEMA IN AN INTUBATED OBESE PATIENT. ( 27382824 )
2016
15
Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. ( 27644192 )
2016
16
Chemokines in High Altitude Pulmonary Edema. ( 27605749 )
2016
17
Negative pressure pulmonary edema following cervical disc hernia surgery. ( 27916267 )
2016
18
Angiotensin II Receptor 1 gene variants are associated with high-altitude pulmonary edema risk. ( 27732943 )
2016
19
Tumbling Downhill: Unilateral Pulmonary Edema. ( 27427322 )
2016
20
Elevated blood plasma levels of epinephrine, norepinephrine, tyrosine hydroxylase, TGFI^1, and TNFI+ associated with high-altitude pulmonary edema in an Indian population. ( 27540296 )
2016
21
Role of PiCCO monitoring for the integrated management of neurogenic pulmonary edema following traumatic brain injury: A case report and literature review. ( 27698733 )
2016
22
Endovascular Treatment for Aneurysmal Subarachnoid Hemorrhage with Neurogenic Pulmonary Edema in the Acute Stage. ( 27560529 )
2016
23
Refractory Pulmonary Edema Caused by Late Pulmonary Vein Thrombosis After Lung Transplantation: A Rare Adverse Event. ( 27549541 )
2016
24
Solnatide demonstrates profound therapeutic activity in a rat model of pulmonary edema induced by acute hypobaric hypoxia and exercise. ( 27815150 )
2016
25
Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction. ( 27127397 )
2016
26
Pulmonary Embolism Masquerading as High Altitude Pulmonary Edema at High Altitude. ( 27768392 )
2016
27
Baroreflex failure increases the risk of pulmonary edema in conscious rats with normal left ventricular function. ( 26589328 )
2016
28
Computer-aided quantitative ultrasonography for detection of pulmonary edema in mechanically ventilated cardiac surgery patients. ( 27130285 )
2016
29
RADIOGRAPHIC APPEARANCE OF PRESUMED NONCARDIOGENIC PULMONARY EDEMA AND CORRELATION WITH THE UNDERLYING CAUSE IN DOGS AND CATS. ( 28005303 )
2016
30
An uncommon cause of acute pulmonary edema. ( 27575897 )
2016
31
Right upper lobe pulmonary edema. ( 26976950 )
2016
32
ROCK2 and MYLK variants and high-altitude pulmonary edema. ( 27536156 )
2016
33
Novel drugs in the management of acute mountain sickness and high altitude pulmonary edema. ( 26766920 )
2016
34
Managing High-Altitude Pulmonary Edema with Oxygen Alone: Results of a Randomized Controlled Trial. ( 27906598 )
2016
35
Raised HIF1I+ during normoxia in high altitude pulmonary edema susceptible non-mountaineers. ( 27210110 )
2016
36
Pulmonary Edema Occurring 15 Years After Mitral Valve Replacement. ( 27760258 )
2016
37
Serotonin syndrome presenting as pulmonary edema. ( 26997733 )
2016
38
Posterior Consolidation: An Important Clue for Differentiating ARDS From Cardiogenic Pulmonary Edema. ( 27055705 )
2016
39
Reexpansion pulmonary edema after hepatic hydatid cyst excision. ( 27687398 )
2016
40
Molecular Pathology of Pulmonary Edema in Forensic Autopsy Cases with Special Regard to Fatal Methamphetamine Intoxication. ( 27651022 )
2016
41
Cardiogenic Pulmonary Edema in a Dog Following Initiation of Therapy for Concurrent Hypoadrenocorticism and Hypothyroidism. ( 27685367 )
2016
42
Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema. ( 27378823 )
2016
43
The Effects of Aquaporin-1 in Pulmonary Edema Induced by Fat Embolism Syndrome. ( 27455237 )
2016
44
Acute Pulmonary Edema in an Eclamptic Pregnant Patient: A Rare Case of Takotsubo Syndrome. ( 27658947 )
2016
45
Acute pulmonary edema with new giant V wave immediately after pericardiocentesis. ( 27054499 )
2016
46
Postobstructive Pulmonary Edema following Tonsillectomy/Adenoidectomy in a 2-Year-Old with Poland-Moebius Syndrome. ( 26942029 )
2016
47
Elevated pulmonary artery pressure and brain natriuretic peptide in high altitude pulmonary edema susceptible non-mountaineers. ( 26892302 )
2016
48
Successful management using airway pressure release ventilation for severe postoperative pulmonary edema. ( 27591380 )
2016
49
Selective HDAC6 inhibition prevents TNF-I+-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema. ( 27190059 )
2016
50
Morphine blocks the Mesobuthus tamulus venom-induced augmentation of phenyldiguanide reflex and pulmonary edema in anesthetized rats. ( 26997727 )
2016

Variations for Pulmonary Edema

Expression for Pulmonary Edema

Search GEO for disease gene expression data for Pulmonary Edema.

Pathways for Pulmonary Edema

Pathways related to Pulmonary Edema according to GeneCards Suite gene sharing:

(show all 47)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.97 CFTR CXCL8 EDN1 IL1B NOS2 TNF
2
Show member pathways
12.89 ACE CXCL8 IL10 IL1B NOS2 TNF
3
Show member pathways
12.83 CXCL8 ICAM1 IL10 IL1B TNF
4
Show member pathways
12.78 EDN1 IL1B NOS3 NPPB TRPV4
5
Show member pathways
12.53 F2 IL10 IL1B NOS2 NOS3 TNF
6
Show member pathways
12.33 CFTR CXCL8 ICAM1 NOS2
7
Show member pathways
12.32 CFTR CXCL8 IL1B TNF
8
Show member pathways
12.31 CRP F2 ICAM1 IL1B TNF
9
Show member pathways
12.25 IL10 IL1B NOS2 TNF
10
Show member pathways
12.25 CXCL8 IL1B NOS2 TNF
11 12.22 IL10 IL1B NOS2 TNF
12 12.16 CXCL8 IL10 IL1B TNF
13
Show member pathways
12.14 EDN1 NPPA NPPB TNF
14
Show member pathways
12.13 CXCL8 IL10 IL1B TNF
15
Show member pathways
12.13 CFTR CXCL8 IL1B NOS2 TNF
16 11.95 EDN1 ICAM1 IL1B TNF
17 11.95 CXCL8 ICAM1 IL1B NOS2 TNF
18 11.94 EDN1 ICAM1 IL1B NOS3 TNF TRPV4
19 11.9 EDN1 NOS2 NOS3 NPPA
20 11.87 CXCL8 ICAM1 IL1B TNF
21 11.84 CXCL8 ICAM1 IL1B TNF
22 11.81 CXCL8 IL1B NOS2
23 11.81 CXCL8 IL10 IL1B NOS2 TNF
24
Show member pathways
11.77 ACE NOS3 REN
25 11.77 IL10 IL1B TNF
26 11.74 IL10 IL1B TNF
27 11.69 ICAM1 IL10 NOS2 TNF
28 11.68 CXCL8 IL10 IL1B NOS2 TNF
29 11.64 CXCL8 EDN1 IL1B TNF
30
Show member pathways
11.62 CFTR NOS2 NOS3
31 11.58 CXCL8 IL1B TNF
32
Show member pathways
11.57 CXCL8 ICAM1 IL1B NOS2 TNF
33 11.51 IL1B NOS2 TNF
34 11.49 CXCL8 ICAM1 IL10 IL1B NOS2 TNF
35 11.38 ICAM1 IL1B NOS2
36 11.35 IL10 IL1B TNF
37 11.34 CXCL8 ICAM1 IL10 IL1B TNF
38 11.3 ICAM1 IL10 IL1B TNF
39 11.27 IL10 IL1B TNF
40 11.24 CXCL8 ICAM1 IL10 IL1B TNF
41 11.2 CXCL8 IL10 IL1B TNF
42 11.18 F2 ICAM1 IL1B
43 11.1 CXCL8 EDN1 ICAM1 IL1B NOS3 TNF
44 11.02 CRP CXCL8 TNF
45 10.94 ICAM1 IL1B TNF
46 10.78 CFTR NOS2 NOS3
47 10.58 NOS2 NOS3

GO Terms for Pulmonary Edema

Cellular components related to Pulmonary Edema according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.73 ACE CRP CXCL8 EDN1 F2 IL10
2 external side of plasma membrane GO:0009897 9.46 ACE F2 ICAM1 TNF
3 extracellular space GO:0005615 9.44 ACE CRP CXCL8 EDN1 F2 ICAM1

Biological processes related to Pulmonary Edema according to GeneCards Suite gene sharing:

(show all 46)
id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.97 CRP CXCL8 IL10 IL1B TNF
2 leukocyte migration GO:0050900 9.95 F2 ICAM1 IL1B TNF
3 response to hypoxia GO:0001666 9.86 EDN1 ICAM1 NOS2 NPPA
4 cellular response to interleukin-1 GO:0071347 9.85 CXCL8 EDN1 ICAM1
5 regulation of insulin secretion GO:0050796 9.83 IL1B NOS2 TNF
6 positive regulation of JNK cascade GO:0046330 9.82 IL1B TNF TRPV4
7 neutrophil chemotaxis GO:0030593 9.8 CXCL8 EDN1 IL1B
8 cellular response to interferon-gamma GO:0071346 9.8 EDN1 ICAM1 NOS2
9 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.76 EDN1 IL10 IL1B TNF
10 response to insulin GO:0032868 9.73 ICAM1 IL10 NPPA TRPV4
11 cellular response to lipopolysaccharide GO:0071222 9.72 CXCL8 ICAM1 IL10 NOS2 TNF
12 cellular response to drug GO:0035690 9.71 EDN1 IL1B NOS2 REN
13 positive regulation of urine volume GO:0035810 9.7 EDN1 NPPB
14 positive regulation of renal sodium excretion GO:0035815 9.7 EDN1 NPPB
15 nitric oxide biosynthetic process GO:0006809 9.69 NOS2 NOS3
16 negative regulation of calcium ion transport GO:0051926 9.69 ICAM1 NOS3
17 response to molecule of bacterial origin GO:0002237 9.69 CXCL8 IL10
18 angiotensin maturation GO:0002003 9.68 ACE REN
19 positive regulation of guanylate cyclase activity GO:0031284 9.68 NOS2 NOS3
20 positive regulation of chemokine biosynthetic process GO:0045080 9.68 IL1B TNF
21 receptor guanylyl cyclase signaling pathway GO:0007168 9.68 NPPA NPPB
22 negative regulation of lipid storage GO:0010888 9.67 CRP TNF
23 regulation of blood vessel diameter GO:0097746 9.67 ACE NPPB
24 body fluid secretion GO:0007589 9.66 EDN1 NPPB
25 negative regulation of platelet activation GO:0010544 9.66 F2 NOS3
26 multicellular organismal water homeostasis GO:0050891 9.65 CFTR TRPV4
27 lipopolysaccharide-mediated signaling pathway GO:0031663 9.65 IL1B NOS3 TNF
28 positive regulation of monocyte chemotactic protein-1 production GO:0071639 9.64 IL1B TRPV4
29 endothelial cell apoptotic process GO:0072577 9.63 IL10 TNF
30 response to lipopolysaccharide GO:0032496 9.63 EDN1 ICAM1 IL10 IL1B NOS2 REN
31 positive regulation of prostaglandin secretion GO:0032308 9.62 EDN1 IL1B
32 acute inflammatory response to antigenic stimulus GO:0002438 9.61 ICAM1 SERPINC1
33 arginine catabolic process GO:0006527 9.61 NOS2 NOS3
34 regulation of establishment of endothelial barrier GO:1903140 9.6 IL1B TNF
35 regulation of systemic arterial blood pressure by endothelin GO:0003100 9.59 EDN1 NOS3
36 receptor-mediated virion attachment to host cell GO:0046813 9.58 ACE ICAM1
37 negative regulation of cytokine secretion involved in immune response GO:0002740 9.58 IL10 TNF
38 positive regulation of nitric oxide biosynthetic process GO:0045429 9.56 EDN1 ICAM1 IL1B TNF
39 positive regulation of fever generation GO:0031622 9.55 IL1B TNF
40 sequestering of triglyceride GO:0030730 9.54 IL1B TNF
41 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.54 IL10 IL1B TNF
42 receptor biosynthetic process GO:0032800 9.52 IL10 TNF
43 positive regulation of leukocyte adhesion to vascular endothelial cell GO:1904996 9.51 ICAM1 TNF
44 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.49 IL1B TNF
45 regulation of blood vessel size GO:0050880 9.26 EDN1 NOS3 NPPA NPPB
46 regulation of blood pressure GO:0008217 9.1 ACE EDN1 NOS3 NPPA NPPB REN

Molecular functions related to Pulmonary Edema according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 arginine binding GO:0034618 9.37 NOS2 NOS3
2 cytokine activity GO:0005125 9.35 CXCL8 EDN1 IL10 IL1B TNF
3 NADPH-hemoprotein reductase activity GO:0003958 9.32 NOS2 NOS3
4 tetrahydrobiopterin binding GO:0034617 9.26 NOS2 NOS3
5 nitric-oxide synthase activity GO:0004517 9.16 NOS2 NOS3
6 receptor binding GO:0005102 9.1 EDN1 F2 NOS2 NPPA NPPB REN

Sources for Pulmonary Edema

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....